SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-044833
Filing Date
2019-08-06
Accepted
2019-08-06 16:41:38
Documents
2
Period of Report
2019-08-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 13225
2 EX-24 DOCUMENT attachment1.htm EX-24 3534
  Complete submission text file 0001209191-19-044833.txt   18108
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139
Business Address
Arbuckle Stuart A (Reporting) CIK: 0001557290 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 191002662